These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32940232)

  • 1. Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs.
    Draeger T; Voelkel V; Groothuis-Oudshoorn CGM; Lavric M; Veltman J; Dassen A; Boersma LJ; Witteveen A; Sonke GS; Koffijberg H; Siesling S
    Value Health; 2020 Sep; 23(9):1149-1156. PubMed ID: 32940232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.
    Voelkel V; Draeger T; Groothuis-Oudshoorn CGM; de Munck L; Hueting T; Gerken M; Klinkhammer-Schalke M; Lavric M; Siesling S
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1823-1833. PubMed ID: 30927074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer.
    Witteveen A; de Munck L; Groothuis-Oudshoorn CGM; Sonke GS; Poortmans PM; Boersma LJ; Smidt ML; Vliegen IMH; IJzerman MJ; Siesling S
    Oncologist; 2020 Sep; 25(9):e1330-e1338. PubMed ID: 32510767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
    Witteveen A; Vliegen IM; Sonke GS; Klaase JM; IJzerman MJ; Siesling S
    Breast Cancer Res Treat; 2015 Aug; 152(3):627-36. PubMed ID: 26162567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-based breast cancer follow-up stratified by age.
    Witteveen A; Otten JWM; Vliegen IMH; Siesling S; Timmer JB; IJzerman MJ
    Cancer Med; 2018 Oct; 7(10):5291-5298. PubMed ID: 30207076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.
    Völkel V; Hueting TA; Draeger T; van Maaren MC; de Munck L; Strobbe LJA; Sonke GS; Schmidt MK; van Hezewijk M; Groothuis-Oudshoorn CGM; Siesling S
    Breast Cancer Res Treat; 2021 Oct; 189(3):817-826. PubMed ID: 34338943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.
    de Ligt KM; Witteveen A; Siesling S; Steuten LMG
    BMC Cancer; 2018 Jan; 18(1):96. PubMed ID: 29361911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis.
    Eijkelboom AH; de Munck L; de Vries M; Francken AB; Hendriks MP; Strobbe L; Witteveen A; van Maaren MC; Siesling S
    Breast Cancer Res Treat; 2023 Jan; 197(1):123-135. PubMed ID: 36315307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis.
    Draeger T; Voelkel V; Schreuder K; Veltman J; Dassen A; Strobbe L; Heijmans HJ; Koelemij R; Groothuis-Oudshoorn CGM; Siesling S
    Oncologist; 2022 Oct; 27(10):e766-e773. PubMed ID: 35962739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient-level calibration framework for evaluating surveillance strategies: a case study of mammographic follow-up after early breast cancer.
    Bessen T; Karnon J
    Value Health; 2014 Sep; 17(6):669-78. PubMed ID: 25236990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation.
    Wobb JL; Chen PY; Shah C; Moran MS; Shaitelman SF; Vicini FA; Mbah AK; Lyden M; Beitsch P
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):312-8. PubMed ID: 25446607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
    Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes.
    Adra J; Lundstedt D; Killander F; Holmberg E; Haghanegi M; Kjellén E; Karlsson P; Alkner S
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):285-295. PubMed ID: 31212042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty.
    Ankersmid JW; Spronk PER; Zeillemaker AM; Siesling S
    Breast Cancer Res Treat; 2022 Jun; 193(2):293-303. PubMed ID: 35279762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk.
    Voets MM; Hassink NS; Veltman J; Slump CH; Koffijberg H; Siesling S
    Breast Cancer Res Treat; 2024 Jun; 205(2):313-322. PubMed ID: 38409613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.
    van Nes JG; Putter H; van Hezewijk M; Hille ET; Bartelink H; Collette L; van de Velde CJ;
    Eur J Surg Oncol; 2010 Jul; 36(7):617-24. PubMed ID: 20558026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Logistic Regression and Bayesian Networks for Risk Prediction of Breast Cancer Recurrence.
    Witteveen A; Nane GF; Vliegen IMH; Siesling S; IJzerman MJ
    Med Decis Making; 2018 Oct; 38(7):822-833. PubMed ID: 30132386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.